### References:

1. Supporting references for therapeutic utility of epigenetic reprogramming:


    | Disease Model | Intervention | Reference |
    | --- | --- | --- |
    | Type I diabetes | Partial OSKM, transgenic | https://pubmed.ncbi.nlm.nih.gov/27984723/ |
    | Skeletal muscle injury | Partial OSKM, transgenic | https://pubmed.ncbi.nlm.nih.gov/27984723/ |
    | Skeletal muscle injury | OSKMLN, mRNA + LNPs | https://pubmed.ncbi.nlm.nih.gov/32210226/ |
    | Skeletal muscle injury | OSKM, transgenic | https://pubmed.ncbi.nlm.nih.gov/34035273/ |
    | Glaucoma | Partial OSK, AAV | https://pubmed.ncbi.nlm.nih.gov/33268865/ |
    | Myocardial infarction | Partial OSKM, transgenic | https://pubmed.ncbi.nlm.nih.gov/34554778/ |
    | Skin wound healing | Partial OSKM, transgenic | https://pubmed.ncbi.nlm.nih.gov/29761584/ |
    | Skin wound healing | Partial OSKM, long-term, transgenic | https://www.nature.com/articles/s43587-022-00183-2#Sec28 |
    | Liver regeneration | Partial OSKM, transgenic | https://pubmed.ncbi.nlm.nih.gov/35476977/ |
